The market is buzzing after a cooler-than-expected CPI report, but the real action is in Eli Lilly (LLY). With a 6.59% drop following disappointing sales and lowered guidance, LLY might seem like a lost cause—but that’s exactly why it’s an opportunity. With no earnings report in sight and volatility expectations for this Friday’s options expiration soaring, the stage is set for a strategic, high-probability trade. In today’s newsletter, we break down how to capitalize on this unique setup and turn market mispricing into your next big win. Don’t miss it!
©2025 WhatAreOptions.com LLC